Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 16;57(9):972.
doi: 10.3390/medicina57090972.

The Influence of Serum Uric Acid Level on Non-Motor Symptoms Occurrence and Severity in Patients with Idiopathic Parkinson's Disease and Atypical Parkinsonisms-A Systematic Review

Anna Grażyńska  1 , Klaudia Adamczewska  1 , Sofija Antoniuk  1 , Martyna Bień  1 , Mateusz Toś  2 , Jakub Kufel  3 , Weronika Urbaś  4 , Joanna Siuda  2
Affiliations

The Influence of Serum Uric Acid Level on Non-Motor Symptoms Occurrence and Severity in Patients with Idiopathic Parkinson's Disease and Atypical Parkinsonisms-A Systematic Review

Anna Grażyńska et al. Medicina (Kaunas). .

Abstract

Background and Objectives: A growing number of studies correlated higher levels of serum uric acid (UA) with both: lower risk of Parkinson's Disease (PD) occurrence and slower progression of the disease. Similar conclusions were made where studies correlated UA with atypical Parkinsonisms (AP) progression. A few researchers have studied the issue of the influence of serum UA on the occurrence of non-motor symptoms (NMS) in PD and AP. Our systematic review is the first review completely dedicated to this matter. Materials and Methods: A comprehensive evaluation of the literature was performed to review the relationship between UA and NMS in PD and AP. The systematic review was conducted according to PRISMA Statement guidelines. The following databases were searched starting in April 2021: MEDLINE via PubMed, Embase, and Scopus. During the research, the following filters were used: >2010, articles in English, concerning humans. The study was not registered and received no external funding. Results: Seven articles meeting all inclusion criteria were included in this study. Collectively, data on 1104 patients were analyzed. A correlation between serum UA concentration and a few NMS types has been provided by the analyzed studies. In four papers, sleep disorders and fatigue were related to UA for both advanced and early PD. Other commonly appearing NMS domains were Attention/memory (4 studies), Depression/anxiety (3 studies), Cardiovascular (3 studies), Gastrointestinal (1 study), Perceptual (1 study), and Miscellaneous (1 study). For AP, no significant correlation between UA and worsening of NMS has been found. Conclusions: Based on the analyzed studies, a correlation between serum UA level and the occurrence and worsening of NMS in PD and APs cannot be definitively determined. Large-scale studies with a more diverse patient population and with more accurate methods of NMS assessment in Parkinsonism are needed.

Keywords: Parkinson’s disease; atypical Parkinsonism; cognitive disorders; non-motor symptoms; sleep disorders; uric acid.

PubMed Disclaimer

Conflict of interest statement

The authors declared no potential conflict of interest with respect to the research, authorship, and/or publication of this article. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
PRISMA flow diagram. For more information, visit: http://www.prisma-statement.org/ (accessed on 15 September 2021).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Jesús S., Pérez I., Cáceres-Redondo M.T., Carrillo F., Carballo M., Gómez-Garre P., Mir P. Low serum uric acid concentration in Parkinson’s disease in southern Spain. Eur. J. Neurol. 2012;20:208–210. doi: 10.1111/j.1468-1331.2012.03745.x. - DOI - PubMed
    1. Schwarzschild M.A., Ascherio A., Beal M.F., Cudkowicz M.E., Curhan G.C., Hare J.M., Hooper D.C., Kieburtz K.D., Macklin E., Oakes D., et al. Inosine to Increase Serum and Cerebrospinal Fluid Urate in Parkinson Disease: A Randomized Clinical Trial. JAMA Neurol. 2014;71:141–150. doi: 10.1001/jamaneurol.2013.5528. - DOI - PMC - PubMed
    1. Schlesinger I., Schlesinger N. Uric acid in Parkinson’s disease. Mov. Disord. 2008;23:1653–1657. doi: 10.1002/mds.22139. - DOI - PubMed
    1. Ou R., Cao B., Wei Q., Hou Y., Xu Y., Song W., Zhao B., Shang H. Serum uric acid levels and freezing of gait in Parkinson’s disease. Neurol. Sci. 2017;38:955–960. doi: 10.1007/s10072-017-2871-3. - DOI - PubMed
    1. Weisskopf M.G., O’Reilly E., Chen H., Schwarzschild M.A., Ascherio A. Plasma Urate and Risk of Parkinson’s Disease. Am. J. Epidemiol. 2007;166:561–567. doi: 10.1093/aje/kwm127. - DOI - PMC - PubMed

Publication types